You are here

Medicine Access @ Point of Care

Medicine Access @ Point of Care


Managing Editor
Samantha Taylor SAGE Publishing Ltd, UK
Consulting Editor
Giulio Zuanetti Milan, Italy


eISSN: 23992026 | ISSN: 23992026

Medicine Access @ Point of Care (MAP) is a peer-reviewed, open access journal, which focusses on delivering the highest quality peer-reviewed articles, reviews and scholarly comment on access to medicine. The journal has a strong clinical focus and is aimed at an international audience of pharmacists, clinicians, medical ethicists, regulators and researchers, providing an online forum for rapid dissemination of recent research and perspectives in this area. Please see the Aims and Scopes tab for further information.

This journal a member of the Committee on Publication Ethics (COPE).

Why publish in Medicine Access @ Point of Care?

  • Rigorous peer review of your research
  • Multidisciplinary audience
  • Open access format, driving high visibility and global exposure
  • Prompt online publication
  • Authors retain copyright under a Creative Commons license

Open access article processing charge (APC) information

This journal does not currently charge an article processing charge for open access publication as an introductory offer.

As of 1st January 2019 the APC will increase to 750 USD. The APC is based on the date of the original submission of the article. Therefore, all articles submitted before 31st December 2018 will remain eligible for the introductory offer regardless of the article’s date of acceptance.

Submission information

Submit your manuscript today at http://mc.manuscriptcentral.com/maapoc

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.

Contact

Please direct any queries to samantha.taylor@sagepub.co.uk

Other Information

Previously published by Wichtig International Ltd


 

Medicine Access @ Point of Care is an open access journal which delivers the highest quality peer-reviewed content dealing with access to medicine in the broadest sense. The journal has a strong clinical focus and is aimed at an international audience of pharmacists, clinicians, medical ethicists, regulators and researchers, providing an online forum for rapid dissemination of recent research and perspectives in this area.

The editors welcome submissions across all areas of access to medicines including but not limited to compassionate use of medicine, global access, early access, treatment of rare diseases, off-label drug uses, and any situation where an unmet clinical need requires treatment which is not, or not yet, licensed or available. The journal also deals with relevant topics such as regulatory compliance, counterfeit medicines and responding to patient demand outside of traditional access routes.

The journal publishes original research articles and review articles primarily. Patient perspective articles and point of view articles are solicited by the Editors. Letters to the Editor and Case Reports will also be considered.

The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees; a first editorial decision is generally reached within 3 weeks of submission and online first publication is usually within 3 weeks of acceptance.

Editorial Board Member
Dr Felipe Ades Hospital Israelita Albert Einstein, Brazil
Dr Roger Bate American Enterprise Institute, USA
Mr. Reed Beall University of Calgary, Canada
Mr. Carl Booth Airedale NHS Foundation Trust, UK
Professor Alan Boyd The Faculty of Pharmaceutical Medicine, UK
Dr. Steve Bradshaw Valid Insight, UK
Mr Bruce Burnett University of Central Lancashire, UK
Dr. Arthur Caplan NYU School of Medicine, USA
Tarik Catic Society for Pharmacoeconomics and Outcomes Research, Bosnia and Herzegovina
Dr Eduardo Cazap Latin American and Caribbean Society of Medical Oncology, Argentina
Ms. Romana Cecchele Royal Prince Alfred Hospital, Australia
Mr. Domenico Di Giorgio Italian Medicines Agency - AIFA, Italy
Dr Erin Fox University of Utah Health Care, USA
Dr Roberto Frontini University of Leipzig, Germany
Professor Isabelle Huys KU Leuven, Belgium
Mr. Mike Isles European Alliance for Access to Safe Medicines, UK
Güvenç Koçkaya Health Economics & Policy Association, Turkey
Professor Jillian Clare Kohler University of Toronto, Canada
Mr. Eric Lau Prince of Wales Hospital and Community Health Services, Australia
Ms. Laura Lyons Mater Misericordiae University Hospital, Ireland
Dr Timothy Mackey University of California, San Diego, USA
Professor Paola Minghetti Universita degli Studi di Milano, Italy
Professor Elias Mossialos The London School of Economics and Political Science, UK
Mr. Bernard Naughton Keele University, UK
Dr. Wayne Nicholls Children's Health Queensland Hospital and Health Service, Australia
Dr Barbara Rebesco ICRRS AOU San Martino IST, National Institute for Cancer Research, Italy
Dr Valerio Reggi Universitat Autonoma De Barcelona, Spain
Professor Mark Sonderup University of Capetown Faculty of Health Sciences and Groote Schuur Hospital, South Africa
Dr Stephen Tomlin Evelina London Children's Hospital, UK
Mr Pavle Zelic Medicines and Medical Devices Agency of Serbia, Serbia

 

  1. Open Access
  2. Article processing charge (APC)
  3. What do we publish?
    3.1 Aims & scope
    3.2 Article types
    3.3 Writing your paper
  4. Editorial policies
    4.1 Peer review policy
    4.2 Authorship
    4.3 Acknowledgements
    4.4 Funding
    4.5 Declaration of conflicting interests
    4.6 Research ethics and patient consent
    4.7 Clinical trials
    4.8 Reporting guidelines
    4.9 Data
  5. Publishing policies
    5.1 Publication ethics
    5.2 Contributor's publishing agreement
  6. Preparing your manuscript
    6.1 Word processing formats
    6.2 Artwork, figures and other graphics
    6.3 Supplementary material
    6.4 Reference style
    6.5 English language editing services
  7. Submitting your manuscript
    7.1 How to submit your manuscript
    7.2 Title, keywords and abstracts
    7.3 Information required for completing your submission
    7.4 ORCID
    7.5 Permissions
  8. On acceptance and publication
    8.1 SAGE Production
    8.2 Online publication
    8.3 Promoting your article
  9. Further information

This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

Please read the guidelines below then visit the journal’s submission site https://mc.manuscriptcentral.com/maapoc to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

Only manuscripts of sufficient quality that meet the aims and scope of Medicine Access @ Point of Care will be reviewed.

As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

1. Open Access

Medicine Access @ Point of Care is an open access, peer-reviewed journal. Each article accepted by peer review is made freely available online immediately upon publication, is published under a Creative Commons license and will be hosted online in perpetuity. There is no charge for submitting or publication in this journal.

For general information on open access at SAGE please visit the Open Access page or view our Open Access FAQs.

Return to top

2. Article processing charge (APC)

There is no article processing charge (APC) for this journal.

Return to top

3. What do we publish?

3.1 Aims & scope

Before submitting your manuscript to Medicine Access @ Point of Care, please ensure you have read the Aims & Scope.

3.2 Article types

Ethical statements: Mandatory statements for all submissions: All submissions to Medicine Access @ Point of Care should include a statement confirming that the submission meets each of the below criteria. In the case of a statement being not applicable, ‘not applicable’ or ‘n/a’ is insufficient, and an explanation must be provided. In these cases the Editors expect to see the details of the Ethics Committee or Review Board that waived approval, including names and institutions of the relevant committee or a brief explanation.  

- Acknowledgements (see section 4.3)
- Authorship (see section 4.2)
- Funding (see section 4.4)
- Availability of data and materials (see section 4.9)
- Conflict of interest (see section 4.5)
- Informed consent (see section 4.6)
- Ethical approval (see section 4.6)
- Human rights (see section 4.6)

Research @ Point of Care articles

Previously unpublished manuscripts describing research studies and study protocols aimed at improving patients care or the practical application of research findings at Point of Care.

Typical examples would include observational studies in consecutive patient’s series in a daily setting, real world evidence (RWE) studies, big data based studies, proof of concept observations at bedside, application of narrative medicine in the clinical setting, use of alternative medicine etc.. (If your study refers to application of a specific application of a novel technology at the point of care, please refer below to Technology @ Point of Care articles).

Manuscripts should be structured as follows: Structured abstract (including Background, Aim, Methods, Results, Conclusion), Introduction (clearly stating an objective or hypothesis), Methods (describing the study design and methods applied, including the study setting and dates, patients or participants with inclusion and exclusion criteria if applicable, and/or participation or response rates, or data sources, and how these were selected for the study), Results (describing the results of the study in context with the published literature and addressing study limitations), Discussion (addressing relevant implications for clinical practice or health policy) and Conclusion.

Words: max 3000 (excluding figures and tables)
Figures/Tables: max 6
References: max 50

Technology @ Point of Care articles

Previously unpublished manuscripts, describing the application of technology in its widest definition in the diagnosis, treatment and follow-up of patients.

Typical examples would include novel diagnostic tools in-hospital, in ambulatory settings and at home, wearable devices for monitoring physiological variables during daily life; devices for facilitating drug administration; applications of telemedicine and tele health; applications for improving patients compliance to medications etc.

Manuscripts should be structured as follows: Structured abstract (including Background, Aim, Methods, Results, Conclusion), Introduction (clearly stating an objective or hypothesis), Methods (describing the study design and methods applied, including the study setting and dates, patients or participants with inclusion and exclusion criteria, and/or participation or response rates, or data sources, and how these were selected for the study), Results (describing the results of the study in context with the published literature and addressing study limitations), and Conclusions (addressing relevant implications for clinical practice or health policy).

Words: max 3000 (excluding figures and tables)
Figures/Tables: max 6
References: max 50

Patients @ Point of Care articles

Patients @ Point of Care articles will be accepted if they describe a previously undescribed clinical case and are of very high importance for dissemination.

Articles must be structured as follows: Structured abstract (including Background, Case Presentation and Conclusions), Introduction (explaining the importance of the case), Patient Presentation (providing all relevant information), and Conclusions (describing the detailed outcome of the report). Please note that informed patient consent to publish must be obtained, and a statement confirming this must be included in the manuscript. Any manuscripts not containing this statement will be returned to the authors.

Words: max 2000 (excluding figures and tables)
Figures/Tables: max 3
References: max 10

Questions @ Point of Care articles

Questions @ Point of Care articles are solicited by the Editor-in-Chief on topics that are deemed to be relevant to the audience of the Journal. Starting with a description of a typical or atypical case, the structure of the articles is based on a series of questions, possibly but not necessarily in logical or chronological sequence that helps the readers in highlighting the clinical reasoning underpinning diagnostic, therapeutic and follow up decisions in the single patient. A structured abstract is required, andshould contain a brief description of the case setting followed by a list of the questions included in the manuscript, with the same sequence.

Words: max 5000 (excluding figures and tables)
Figures/Tables: max 8
References: no limit

Reviews

Review articles are welcome on topics that are deemed to be relevant to the audience of the Journal. Containing the current state of knowledge or practice, integrating recent advances with accepted principles and practice, or summarizing and analyzing consensus view of controversial issues in knowledge of practice. A structured abstract is required.

Words: max 5000 (excluding figures and tables)
Figures/Tables: max 8
References: no limit

Editorials (Invitation only)

The purpose of the editorials is to provide the reader with a balanced overview of relevant and up to date subjects concerning the Journal's aim or future direction. A non-structured abstract is required.

Words: max 4000 (excluding figures and tables)
Figures/Tables: max 8
References: no limit

Point of View...

A leading expert in the field reports their opinion on a controversial issue as requested by the Editor in Chief. A structured abstract is required.

Words: max 5000 (excluding figures and tables)
Figures/Tables: max 8
References: max 70

Correspondence

Letters to the Editor are intended to present opinions or comments on articles published in the Journal. Letters are subject to abridgement and editing for style and content.

Words: max 500 (excluding figures and tables)
Figures/Tables: 1
References: max 5

3.3 Writing your paper

The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.

3.3.1 Making your article discoverable

When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online

Return to top

4. Editorial policies

4.1 Peer review policy

Following a preliminary triage to eliminate submissions unsuitable for Medicine Access @ Point of Care all papers are sent out for review. The covering letter is important. To help the Editor in his preliminary evaluation, please indicate why you think the paper suitable for publication. If your paper should be considered for fast-track publication, please explain why.

The journal’s policy is to have manuscripts reviewed by two expert reviewers. Medicine Access @ Point of Care utilizes a single-blind peer review process in which the reviewer’s name and information is withheld from the author. All manuscripts are reviewed as rapidly as possible, while maintaining rigor. Reviewers make comments to the author and recommendations to the Editor-in-Chief who then makes the final decision.

As part of the submission process you will be asked to provide the names of three peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:

  • The reviewer should have no prior knowledge of your submission
  • The reviewer should not have recently collaborated with any of the authors
  • Reviewer nominees from the same institution as any of the authors are not permitted

You will also be asked to nominate peers who you do not wish to review your manuscript (opposed reviewers).

Please note that the Editors are not obliged to invite any recommended/opposed reviewers to assess your manuscript.

The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor / Board member will have no involvement in the decision-making process.

4.2 Authorship

Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors. The list of authors should include all those who can legitimately claim authorship. This is all those who:

  • Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
  • Drafted the article or revised it critically for important intellectual content,
  • Approved the version to be published,
  • Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

Authors should meet the conditions of all of the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship. 

4.3 Acknowledgements

All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

4.3.1 Writing assistance

Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance.

It is not necessary to disclose use of language polishing services.

 Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.

4.4 Funding

Medicine Access @ Point of Care requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. 

4.5 Declaration of conflicting interests

It is the policy of Medicine Access @ Point of Care to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.

Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.

For guidance on conflict of interest statements, please see the ICMJE recommendations.

4.6 Research ethics and patient consent

Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.

Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.

Please also refer to the ICMJE Recommendations for the Protection of Research Participants

All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors

4.7 Clinical trials

Medicine Access @ Point of Care endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be included at the end of the abstract.

4.8 Reporting guidelines

The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.

Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.

4.9 Data

SAGE acknowledges the importance of research data availability as an integral part of the research and verification process for academic journal articles.

Medicine Access @ Point of Care requests all authors submitting any primary data used in their research articles alongside their article submissions to be published in the online version of the journal, or provide detailed information in their articles on how the data can be obtained. This information should include links to third-party data repositories or detailed contact information for third-party data sources. Data available only on an author-maintained website will need to be loaded onto either the journal’s platform or a third-party platform to ensure continuing accessibility. Examples of data types include but are not limited to statistical data files, replication code, text files, audio files, images, videos, appendices, and additional charts and graphs necessary to understand the original research. The editor may consider limited embargoes on proprietary data. The editor(s) can also grant exceptions for data that cannot legally or ethically be released. All data submitted should comply with Institutional or Ethical Review Board requirements and applicable government regulations. For further information, please contact the editorial office at samantha.taylor@sagepub.co.uk.

Return to top

5. Publishing policies

5.1 Publication ethics

SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.

5.1.1 Plagiarism

Medicine Access @ Point of Care and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.

5.1.2 Prior publication

If material has been previously published, it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.

5.2 Contributor's publishing agreement

Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement.  Medicine Access @ Point of Care publishes manuscripts under Creative Commons licenses. The standard license for the journal is Creative Commons by Attribution Non-Commercial (CC BY-NC), which allows others to re-use the work without permission as long as the work is properly referenced and the use is non-commercial. For more information, you are advised to visit SAGE's OA licenses page.

Alternative license arrangements are available, for example, to meet particular funder mandates, made at the author’s request.

Return to top

6. Preparing your manuscript

6.1 Word processing formats

The preferred format for your manuscript is Word. LaTeX files are also accepted. Templates are available on the Manuscript Submission Guidelines page of our Author Gateway.

6.2 Artwork, figures and other graphics

For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines

Figures supplied in color will appear in color online.

6.3 Supplementary material

This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. These will be subjected to peer-review alongside the article. For more information please refer to our guidelines on submitting supplementary files, which can be found within our Manuscript Submission Guidelines page.

6.4 Reference style

Medicine Access @ Point of Care adheres to the SAGE Vancouver reference style. Please review the guidelines on SAGE Vancouver to ensure your manuscript conforms to this reference style.

If you use EndNote to manage references, you can download the SAGE Vancouver output file here.

6.5 English language editing services

Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.

Return to top

7. Submitting your manuscript

7.1 How to submit your manuscript

Please submit your manuscript at https://mc.manuscriptcentral.com/maapoc

7.2 Title, keywords and abstracts

Please supply a title, short title, an abstract and keywords to accompany your article. The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting the SAGE Journal Author Gateway for guidelines on How to Help Readers Find Your Article Online.

7.3 Information required for completing your submission

Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.

You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).

7.4 ORCID

As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a persistent digital identifier that distinguishes researchers from every other researcher and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities ensuring that their work is recognized.

We encourage all authors to add their ORCIDs to their SAGE Track accounts and include their ORCIDs as part of the submission process. If you don’t already have one you can create one here.

7.5 Permissions

Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.

Return to top

8. On acceptance and publication

If your paper is accepted for publication after peer review, you will first be asked to complete the contributor’s publishing agreement.

8.1 SAGE Production

Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorizing the change.

8.2 Online publication

One of the many benefits of publishing your research in an open access journal is the speed to publication. With no page count constraints, your article will be published online in a fully citable form with a DOI number as soon as it has completed the production process. At this time it will be completely free to view and download for all.

8.3 Promoting your article

Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice. In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich, share, and measure the impact of their article. Find out how to maximize your article’s impact with Kudos.

Return to top

9. Further information

Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the Medicine Access @ Point of Care editorial office as follows: samantha.taylor@sagepub.co.uk

 

Return to top